NorthLinks Bio
PrivateLast Round
Series A
Jun 23, 2026
Total Funding Raised
$34M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
NorthLinks Bio is a biotechnology company developing broad-spectrum antiviral preventative medicines for respiratory viral infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorthLinks Bio Comparables
Compare NorthLinks Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leyden Labs | 81% | |
| Pulmotect | 79% | |
| RQ Biotechnology Limited | 74% | |
NorthLinks Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 23, 2026 |
NorthLinks Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
$34M raised, led by RA Capital Management.
NorthLinks Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NorthLinks Bio's valuation, stock price, and market status.